Loading…

Functionalized chitosan as a promising platform for cancer immunotherapy: A review

Immunotherapy is an emerging treatment option for use following traditional cancer treatments (surgical resection, radiotherapy and chemotherapy). Due to the complexity of the tumor environment, a single immunotherapy drug cannot readily reach the target site and frequently causes adverse reactions....

Full description

Saved in:
Bibliographic Details
Published in:Carbohydrate polymers 2022-08, Vol.290, p.119452, Article 119452
Main Authors: Liang, Xiaoyan, Mu, Min, Fan, Rangrang, Zou, Bingwen, Guo, Gang
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immunotherapy is an emerging treatment option for use following traditional cancer treatments (surgical resection, radiotherapy and chemotherapy). Due to the complexity of the tumor environment, a single immunotherapy drug cannot readily reach the target site and frequently causes adverse reactions. Chitosan has been used in this emerging field because of its biodegradable, biocompatible, nonimmunogenic and nontoxic properties. Chitosan has been used as a carrier of immunotherapeutic agents to improve bioavailability, regulate the immune system and enhance antitumor response. The easily modified structure of chitosan allows for the construction of many different delivery vectors for better application in immunotherapy. Here, we review the recent applications of chitosan and its derivatives as delivery vectors in cancer immunotherapy, as well as discuss limitations and clarify current trends and future directions. In conclusion, chitosan has a promising future as a delivery material in immunotherapy. [Display omitted]
ISSN:0144-8617
1879-1344
DOI:10.1016/j.carbpol.2022.119452